ESOT’s ECTORS (The European Cell Therapy and Organ Regeneration Section) is excited to announce the addition of four outstanding professionals to its network. These new members will play a pivotal role in advancing transplantation science and fostering collaboration across Europe:
- Anil Dhawan – Director, Research and Innovation, King’s College Hospital (London, United Kingdom)
- Mekhola Hoff – Consultant Transplant Surgeon, Royal Infirmary of Edinburgh and Honorary Senior Clinical Lecturer, University of Edinburgh (Edinburgh, Scotland, United Kingdom)
- Franziska Olm – Senior Researcher/Lab Manager in Translational Lung Transplantation and Lung Cell Therapy Research at Region Skåne, VO Thorax, and Board Member and Head of ATMP Development, The Bridge Lungs for Life – EU Interreg Project (Lund, Sweden)
- Clara Steichen – Associate Researcher/Resident in Medical Biology, Cell Therapy, and Regenerative Medicine in Organ Transplantation (Poitiers, France)
ECTORS is central to ESOT’s mission of driving progress in cell therapy and organ regeneration. By bringing together scientists and clinicians, the section fosters collaboration, accelerates the translation of research into clinical applications, and ultimately improves patient outcomes across Europe and beyond.
With their expertise and vision, these new members are set to shape the future of transplant science and strengthen the ECTORS community.
We warmly welcome Anil, Mekhola, Franziska, and Clara to ECTORS and invite the broader community to congratulate them.
Learn more about ECTORS: https://esot.org/ectors/
Whether you are a scientist, researcher, clinician, or student, ECTORS provides unique opportunities to connect, collaborate, and grow within the transplantation field.
Not yet an ESOT member? Explore membership options and community affiliation via the Community section.
